Intensive care unit acquired weakness (ICUAW) is a common neuromuscular complication of critical illness, impacting patients’ recovery and long-term outcomes. However, limited evidence is available on pooled prevalence and risk factors of ICUAW specifically in the COVID-19-infected population.
Methods
We searched on PubMed, Embase, Cochrane Library, Web of Science, PEDro, and EBSCOhost/CINAHL up to January 31, 2024. Data synthesis was conducted using the Freeman-Tukey double-arcsine transformation model for the pooled prevalence rate and odds ratios with corresponding 95% confidence intervals was used to identify risk factors.
Results
The pooled prevalence of ICUAW in COVID-19 patients was 55% in eight studies on 868 patients. Risk factors for developing ICUAW in these patients were: old age (WMD 4.78, 95% CI, 1.06-8.49), pre-existing hypertension (OR = 1.63, 95% CI, 1.02-2.61), medical intervention of prone position (OR = 5.21, 95% CI, 2.72-9.98), use of neuromuscular blocking agents (NMBA) (OR = 12.04, 95% CI, 6.20-23.39), needed tracheostomy (OR = 18.07, 95% CI, 5.64-57.92) and renal replacement therapy (RRT) (OR = 5.24, 95% CI = 2.36-11.63).
Conclusions
The prevalence of ICUAW in patients with COVID-19 was considered relatively high. Older age, pre-existing hypertension, medical intervention of prone position, NMBA use, needed tracheostomy and RRT were likely risk factors. In the future, interdisciplinary medical team should pay attention to high-risk groups for ICUAW prevention and early treatments.
SadeghiAEslamiPDooghaie moghadamA, et al.COVID-19 and ICU admission associated predictive factors in Iranian patients. Original article. Caspian J Intern Med.2020;11:512-519. doi:https://doi.org/10.22088/cjim.11.0.512
SchmidtDPivaTCGlaeserSS, et al. Intensive care unit-acquired weakness in patients with COVID-19: occurrence and associated factors. Phys Ther. 2022;102(5):pzac028. doi:https://doi.org/10.1093/ptj/pzac028
4.
QinESHoughCLAndrewsJBunnellAE. Intensive care unit-acquired weakness and the COVID-19 pandemic: a clinical review. PM & R. 2022;14(2):227-238. doi:https://doi.org/10.1002/pmrj.12757
5.
WieskeLDettling-IhnenfeldtDSVerhammeC, et al.Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19(1):196. doi:https://doi.org/10.1186/s13054-015-0937-2
6.
WinkelmanC. Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin Issues. 2004;15(1):74-82. doi:https://doi.org/10.1097/00044067-200401000-00006
7.
PuthuchearyZARawalJMcPhailM, et al.Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591-1600. doi:https://doi.org/10.1001/jama.2013.278481
8.
FriedrichOReidMBVan den BergheG, et al.The sick and the weak: neuropathies/myopathies in the critically ill. Physiol Rev. 2015;95(3):1025-1109. doi:https://doi.org/10.1152/physrev.00028.2014
HermansGVan MechelenHClerckxB, et al.Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410-420. doi:https://doi.org/10.1164/rccm.201312-2257OC
11.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J.2021;372:n71. doi:https://doi.org/10.1136/bmj.n71
12.
HoyDBrooksPWoolfA, et al.Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. Sep 2012;65(9):934-939. doi:https://doi.org/10.1016/j.jclinepi.2011.11.014
13.
StevensRDMarshallSACornblathDR, et al.A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37(10 Suppl):S299-S308. doi:https://doi.org/10.1097/CCM.0b013e3181b6ef67
14.
Tsai YLITJChengYY. Predictors of basic activity in daily living and length of hospitalization in patients with COVID-19. Healthcare (Basel). 2022;10(8):1589. doi:https://doi.org/10.3390/healthcare10081589
15.
FrancelinHSantosDLunardiAPesoCSchujmannDFuC. Association between days of start rehabilitation and development of ICU-acquired weakness in critical ill patients with COVID-19. Am J Respir Crit Care Med. 2022;205:A3186.
16.
MoonenHStrookappeBvan ZantenARH. Physical recovery of COVID-19 pneumosepsis intensive care survivors compared with non-COVID pneumosepsis intensive care survivors during post-intensive care hospitalization: the RECOVID retrospective cohort study. JPEN J Parenter Enteral Nutr. 2022;46(4):798-804. doi:https://doi.org/10.1002/jpen.2242
17.
Núñez-SeisdedosMNLázaro-NavasILópez-GonzálezLLópez-AguileraL. Intensive care unit- acquired weakness and hospital functional mobility outcomes following invasive mechanical ventilation in patients with COVID-19: a single-centre prospective cohort study. J Intensive Care Med. 2022;37(8):1005-1014. doi:https://doi.org/10.1177/08850666221100498
18.
TavaresGSOliveiraCCMendesLPSVellosoM. Muscle strength and mobility of individuals with COVID-19 compared with non-COVID-19 in intensive care. Heart Lung. 2023;62:233-239. doi:https://doi.org/10.1016/j.hrtlng.2023.08.004
19.
Van AerdeNVan den BergheGWilmerAGosselinkRHermansG. Intensive care unit acquired muscle weakness in COVID-19 patients. Intensive Care Med. 2020;46(11):2083-2085. doi:https://doi.org/10.1007/s00134-020-06244-7
20.
YamadaKKitaiTIwataK, et al.Predictive factors and clinical impact of ICU-acquired weakness on functional disability in mechanically ventilated patients with COVID-19. Heart Lung. 2023;60:139-145. doi:https://doi.org/10.1016/j.hrtlng.2023.03.008
21.
LinLXuC. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep. 2020;3(3):e178. doi:https://doi.org/10.1002/hsr2.178
22.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. Br Med J.1997;315(7109):629-634. doi:https://doi.org/10.1136/bmj.315.7109.629
23.
WanXWangWLiuJTongT. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:https://doi.org/10.1186/1471-2288-14-135
24.
WeblinJMcWilliamsD. ICU acquired weakness as a predictor of discharge destination in patients admitted to ICU with COVID-19 requiring mechanical ventilation. 2022.
25.
GonzalezAAbrigoJAchiardiOSimonFCabello-VerrugioC. Intensive care unit-acquired weakness: a review from molecular mechanisms to its impact in COVID-2019. Eur J Transl Myol. 2022;32(3):10511. doi:https://doi.org/10.4081/ejtm.2022.10511
26.
TzotzosSJFischerBFischerHZeitlingerM. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care. 2020;24(1):516. doi:https://doi.org/10.1186/s13054-020-03240-7
27.
PapazianLForelJMGacouinA, et al.Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116. doi:https://doi.org/10.1056/NEJMoa1005372
28.
MossMHuangDTBrowerRG, et al.Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380(21):1997-2008. doi:https://doi.org/10.1056/NEJMoa1901686
29.
AlhazzaniWBelley-CoteEMøllerMH, et al.Neuromuscular blockade in patients with ARDS: a rapid practice guideline. Intensive Care Med. 2020;46(11):1977-1986. doi:https://doi.org/10.1007/s00134-020-06227-8
GonzalezAOrozco-AguilarJAchiardiOSimonFCabello-VerrugioC. SARS-CoV-2/renin–angiotensin system: deciphering the clues for a couple with potentially harmful effects on skeletal muscle. Int J Mol Sci. 2020;21(21):7904. doi:https://doi.org/10.3390/ijms21217904
32.
VersaceVSebastianelliLFerrazzoliD, et al.Case report: myopathy in critically ill COVID-19 patients: a consequence of hyperinflammation?Front Neurol. 2021;12:625144. doi:https://doi.org/10.3389/fneur.2021.625144
33.
AnekweDEBiswasSBussièresASpahijaJ. Early rehabilitation reduces the likelihood of developing intensive care unit-acquired weakness: a systematic review and meta-analysis. Physiotherapy. 2020;107:1-10. doi:https://doi.org/10.1016/j.physio.2019.12.004
34.
ZhangLHuWCaiZ, et al.Early mobilization of critically ill patients in the intensive care unit: a systematic review and meta-analysis. PLoS One. 2019;14(10):e0223185. doi:https://doi.org/10.1371/journal.pone.0223185
35.
FukeRHifumiTKondoY, et al.Early rehabilitation to prevent postintensive care syndrome in patients with critical illness: a systematic review and meta-analysis. BMJ Open. 2018;8(5):e019998. doi:https://doi.org/10.1136/bmjopen-2017-019998
36.
WatanabeSHirasawaJNaitoY, et al.Association between intensive care unit-acquired weakness and early nutrition and rehabilitation intensity in mechanically ventilated patients: a multicenter retrospective observational study. Cureus. 2023;15(4):e37417. doi:https://doi.org/10.7759/cureus.37417
Raurell-TorredàMArias-RiveraSMartíJD, et al.Care and treatments related to intensive care unit-acquired muscle weakness: a cohort study. Aust Crit Care. 2021;34(5):435-445. doi:https://doi.org/10.1016/j.aucc.2020.12.005
39.
YangZWangXWangFPengZFanY. A systematic review and meta-analysis of risk factors for intensive care unit acquired weakness. Medicine (Baltimore). 2022;101(43):e31405. doi:https://doi.org/10.1097/md.0000000000031405
40.
EngelhardtLJGrunowJJWollersheimT, et al.Sex-specific aspects of skeletal muscle metabolism in the clinical context of intensive care unit-acquired weakness. J Clin Med. 2022;11(3):846. doi:https://doi.org/10.3390/jcm11030846
41.
ZhongFZhangHPengYLinXChenLLinY. A predictive nomogram for intensive care-acquired weakness after cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 2024 Jan 25;30(1):23-29. doi: 10.5761/atcs.oa.23-00029.
42.
YangZWangXChangG, et al.Development and validation of an intensive care unit acquired weakness prediction model: a cohort study. Front Med (Lausanne). 2023;10:1122936. doi:https://doi.org/10.3389/fmed.2023.1122936
43.
GoossensCMarquesMBDerdeS, et al.Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness. J Cachexia Sarcopenia Muscle. 2017;8(1):89-101. doi:https://doi.org/10.1002/jcsm.12131
44.
VicenteAAmozaRReidC, et al.Epidemiological characteristics and risk factors of adult patients with intensive care unit-acquired weakness. Rev Am Med Respir. 2020;20:225-234.
45.
CummingsMJBaldwinMRAbramsD, et al.Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study. Lancet. 2020;395(10239):1763-1770. doi:https://doi.org/10.1016/s0140-6736(20)31189-2
46.
BergmanJBallinMNordströmANordströmP. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol.2021;36(3):287-298. doi:https://doi.org/10.1007/s10654-021-00732-w
LoftusTJMooreFAMoldawerLL. ICU-acquired weakness, chronic critical illness, and the persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45(11):e1184. doi:https://doi.org/10.1097/ccm.0000000000002576
LipshutzAKGropperMA. Intensive care unit-acquired muscle weakness: an ounce of prevention is worth a pound of cure. Anesthesiology. 2016;124(1):7-9. doi:https://doi.org/10.1097/aln.0000000000000875
51.
DouglasISRosenthalCASwansonDD, et al.Safety and outcomes of prolonged usual care prone position mechanical ventilation to treat acute coronavirus disease 2019 hypoxemic respiratory failure. Crit Care Med. 2021;49(3):490-502. doi:https://doi.org/10.1097/ccm.0000000000004818
52.
WongtangmanKSanterPWachtendorfLJ, et al.Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019-related acute respiratory distress syndrome: a retrospective cohort study. Crit Care Med. 2021;49(9):1524-1534. doi:https://doi.org/10.1097/ccm.0000000000005053
53.
MalikGRWolfeARSorianoR, et al.Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125(6):e478-e480. doi:https://doi.org/10.1016/j.bja.2020.08.045
54.
GoettlerCEPryorJPReillyPM. Brachial plexopathy after prone positioning. Crit Care. 2002;6(6):540-542. doi:https://doi.org/10.1186/cc1823
55.
BaxFLettieriCMariniA, et al.Clinical and neurophysiological characterization of muscular weakness in severe COVID-19. Neurol Sci. 2021;42(6):2173-2178. doi:https://doi.org/10.1007/s10072-021-05110-8
56.
NakanishiNYoshihiroSKawamuraY, et al.Effect of neuromuscular electrical stimulation in patients with critical illness: an updated systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2023;51(10):1386-1396. doi:https://doi.org/10.1097/ccm.0000000000005941
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
